Pacira BioSciences, Inc. (PCRX) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pacira Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:03.558 -- 00:00:05.558 2024-2025 00:00:06.120 -- 00:00:09.283 PACER Biosciences Earnings Conference Call. 00:00:09.283 -- 00:00:12.886 At this time, all participants are in a listen-only mode. 00:00:12.886 -- 00:00:17.610 After the speaker's presentation, there will be a question and answer session. 00:00:17.610 -- 00:00:23.315 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:23.315 -- 00:00:26.938 You will then hear an automated message advising your hand is raised. 00:00:26.938 -- 00:00:31.342 To withdraw your question, please press star 11 again. 00:00:31.342 -- 00:00:35.375 Please be advised that today's conference is being recorded. 00:00:35.375 -- 00:00:40.522 I would now like to hand the conference over to your speaker today, Susan Mesko, Head 00:00:40.522 -- 00:00:43.883 of Investor Relations. Please go ahead. 00:00:44.787 -- 00:00:49.633 Thank you. Good afternoon, everyone. Welcome to today's conference call to discuss our 00:00:49.633 -- 00:00:53.938 fourth quarter and full year 2025 financial results. 00:00:53.938 -- 00:00:59.104 Joining me are Frank Lee, Chief Executive Officer, Brendan Thien, Chief Commercial 00:00:59.104 -- 00:01:02.772 Officer, and Sean Cross, Chief Financial Officer. 00:01:02.772 -- 00:01:07.820 Before we begin, let me remind you that this call will include forward-looking statements 00:01:07.820 -- 00:01:12.147 subject to the safe harbor provisions of federal securities laws. 00:01:12.147 -- 00:01:18.096 Such statements represent our judgment as of today and may involve risks and uncertainties. 00:01:18.096 -- 00:01:23.665 This may cause our actual results, performance, or achievements to differ materially. 00:01:23.665 -- 00:01:27.832 For information concerning risk factors t...